mercaptopurine Oral Suspension

Brand(s)
Purixan
Category(s)
prescription
SPL Type(s)
Human Prescription
Master SPL
Nova Laboratories, Ltd (2015-03-23)
Oldest Current Product
2014-04-28
License(s)
NDA
RxNORM
ORAL SUSPENSION\MERCAPTOPURINE
FDAOB
ORAL\SUSPENSION\MERCAPTOPURINE
SPL Active
ORAL\SUSPENSION\MERCAPTOPURINE
SPL Moiety
ORAL\SUSPENSION\MERCAPTOPURINE ANHYDROUS

product(s) by strength(s)

mercaptopurine 20 mg/ml oral suspension

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1624840020PurixanNDANova Laboratories, Ltd2014-04-28MERCAPTOPURINEORALSUSPENSIONNDA2059199fd27952-7787-47d9-b6cf-7af2dc38217b

application(s)

#idtitleapplicantapprovedexclusivityapproved drug
1NDA205919PURIXANNOVA LABORATORIES LTD2014-04-28ORPHAN DRUG EXCLUSIVITY [2021-04-28]NDA205919_001

application drug(s)

#idcategory/deprecatedingredient strength(s)routedose formrldapprovedapplication
1NDA205919_001RXMERCAPTOPURINE (20MG/ML)ORALSUSPENSIONTrue2014-04-28PURIXAN

spl(s)

#idtitlecategorytypelabelerlabeler actlast updateversionproduct(s)
19fd27952-7787-47d9-b6cf-7af2dc38217b (view SPL)These highlights do not include all the information needed to use PURIXAN safely and effectively. See full prescribing information for PURIXAN. PURIXAN(R) (mercaptopurine) oral suspension Initial U.S. Approval: 1953prescriptionHuman PrescriptionNova Laboratories, Ltdmanufacture2015-03-2311624840020

Data from: FDAOB, FDAPB, LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII